geoffrey liu
geoffrey liu
Princess Margaret Cancer Centre / University of Toronto
Verified email at
Cited by
Cited by
Ceritinib in ALK-rearranged non–small-cell lung cancer
AT Shaw, DW Kim, R Mehra, DSW Tan, E Felip, LQM Chow, DR Camidge, ...
N Engl j med 370, 1189-1197, 2014
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
RJ Hung, JD McKay, V Gaborieau, P Boffetta, M Hashibe, D Zaridze, ...
Nature 452 (7187), 633-637, 2008
Patient preferences for oral versus intravenous palliative chemotherapy.
G Liu, E Franssen, MI Fitch, E Warner
Journal of Clinical Oncology 15 (1), 110-115, 1997
Probability of cancer in pulmonary nodules detected on first screening CT
A McWilliams, MC Tammemagi, JR Mayo, H Roberts, G Liu, K Soghrati, ...
New England Journal of Medicine 369 (10), 910-919, 2013
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
SY Shen, R Singhania, G Fehringer, A Chakravarthy, MHA Roehrl, ...
Nature 563 (7732), 579-583, 2018
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open …
AT Shaw, TM Kim, L Crinò, C Gridelli, K Kiura, G Liu, S Novello, A Bearz, ...
The Lancet Oncology 18 (7), 874-886, 2017
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
DW Kim, R Mehra, DSW Tan, E Felip, LQM Chow, DR Camidge, ...
The lancet oncology 17 (4), 452-463, 2016
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
AT Shaw, TM Bauer, F de Marinis, E Felip, Y Goto, G Liu, J Mazieres, ...
New England Journal of Medicine 383 (21), 2018-2029, 2020
XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non—Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy
S Gurubhagavatula, G Liu, S Park, W Zhou, L Su, JC Wain, TJ Lynch, ...
Journal of Clinical Oncology 22 (13), 2594-2601, 2004
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
JD McKay, RJ Hung, Y Han, X Zong, R Carreras-Torres, DC Christiani, ...
Nature genetics 49 (7), 1126-1132, 2017
Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
W Zhou, S Gurubhagavatula, G Liu, S Park, DS Neuberg, JC Wain, ...
Clinical Cancer Research 10 (15), 4939-4943, 2004
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
Y Wang, JD McKay, T Rafnar, Z Wang, MN Timofeeva, P Broderick, ...
Nature genetics 46 (7), 736-741, 2014
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review
EL Stewart, SZ Tan, G Liu, MS Tsao
Translational lung cancer research 4 (1), 67, 2015
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma
HI Pass, SM Levin, MR Harbut, J Melamed, L Chiriboga, J Donington, ...
New England Journal of Medicine 367 (15), 1417-1427, 2012
Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations
G Lal, G Liu, B Schmocker, P Kaurah, H Ozcelik, SA Narod, M Redston, ...
Cancer research 60 (2), 409-416, 2000
Polymorphisms in the DNA Repair Genes XRCC1 and ERCC2, Smoking, and Lung Cancer Risk
W Zhou, G Liu, DP Miller, SW Thurston, LL Xu, JC Wain, TJ Lynch, L Su, ...
Cancer Epidemiology Biomarkers & Prevention 12 (4), 359-365, 2003
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non–small-cell lung cancer patients
W Zhou, RS Heist, G Liu, K Asomaning, DS Neuberg, BW Hollis, JC Wain, ...
Journal of Clinical Oncology 25 (5), 479-485, 2007
Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium
DR Brenner, P Boffetta, EJ Duell, H Bickeboeller, A Rosenberger, ...
American journal of epidemiology 176 (7), 573-585, 2012
Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of …
T John, G Liu, MS Tsao
Oncogene 28 (1), S14-S23, 2009
Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer
W Zhou, G Liu, DP Miller, SW Thurston, LL Xu, JC Wain, TJ Lynch, L Su, ...
Cancer research 62 (5), 1377-1381, 2002
The system can't perform the operation now. Try again later.
Articles 1–20